Bevantolol-hydrochloride (SOM Biotech)

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameBevantolol-hydrochloride (SOM Biotech)
Drug Alias NameCI-775NC-1400SOM-3355
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonistsSynaptic vesicular amine transporter inhibitors
TargetsBeta-1 adrenergic receptorSynaptic vesicular amine transporter
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPolandItalyGermany +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNippon Chemiphar Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSom Innovation Biotech SANippon Chemiphar Co Ltd
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A